High Outlier
Strength
5; 10 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078040505
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020364On Market Since
3/3/1995
Pharmacological Classes
Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Decreased Blood Pressure
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
TIAZAC ER 360 MG CAPSULE
Brand
00187261630•Bausch Health US LLC
$2.7628
per EA
TIAZAC ER 360 MG CAPSULE
Brand
00187261690•Bausch Health US LLC
$2.7628
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
NORLIQVA 1 MG/ML SOLUTION
Brand
46287003515•CMP Pharma, Inc.
$3.2067
per ML
CARDIZEM LA 120 MG TABLET
Brand
00187204530•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 120 MG TABLET
Brand
00187204590•Bausch Health US LLC
$3.6467
per EA
CARDIZEM LA 180 MG TABLET
Brand
00187204630•Bausch Health US LLC
$3.8314
per EA